EXISTING PARTNERSHIPSLaboratoires THERABEL LUCIEN PHARMA benefit from numerous strategic alliances in order to develop their pharmaceutical activities in France through commercial partnerships. Numerous licence and joint marketing agreements have also been signed with certain international pharmaceutical groups such as HELSINN, ZAMBON, GALENICA through its subsidiary VIFOR (International) SA.
Licence agreements- VIFOR (International) SA (Switzerland): Venofer,- HELSINN HEALTHCARE (Switzerland): Nexen, Aloxi,- ZAMBON (Italy): Joint marketing of Uridoz.
DEVELOPMENT OBJECTIVES
- acquire new products under licence, and market them in France,- take part in Research and Development projects, together with phase-III joint clinical development programmes.
Contact the Business Development Director
Copyright : THERABEL GROUP COMPANIES 2006